Literature DB >> 1357506

Ondansetron and chest pain.

H S Ballard, G Bottino, J Bottino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1357506     DOI： 10.1016/0140-6736(92)93137-c

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis.

Authors:  E A Perez
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

2.  Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.

Authors:  R M Eglen; C H Lee; W L Smith; L G Johnson; R Clark; R L Whiting; S S Hegde
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

3.  Torsades de Pointes after Ondansetron Infusion in 2 Patients.

Authors:  Danny Y Lee; Tri Trinh; Sion K Roy
Journal:  Tex Heart Inst J       Date:  2017-10-01

4.  Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study.

Authors:  C Yavas; U Dogan; G Yavas; M Araz; O Yavas Ata
Journal:  Support Care Cancer       Date:  2011-12-15       Impact factor: 3.603

Review 5.  Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.

Authors:  Anthony L Kovac
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 6.  Antiemetics in cancer chemotherapy: historical perspective and current state of the art.

Authors:  M Tonato; F Roila; A Del Favero; E Ballatori
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

7.  Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.

Authors:  Antoine Pariente; Paul Avillach; Francesco Salvo; Frantz Thiessard; Ghada Miremont-Salamé; Annie Fourrier-Reglat; Françoise Haramburu; Bernard Bégaud; Nicholas Moore
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

8.  The acute effect of tropisetron on ECG parameters in cancer patients.

Authors:  Ozlem Yavas; Mehmet Yazici; Onder Eren; Cem Boruban; Mehmet Artac; Mine Genc
Journal:  Support Care Cancer       Date:  2008-02-01       Impact factor: 3.603

9.  Block of the delayed rectifier current (IK) by the 5-HT3 antagonists ondansetron and granisetron in feline ventricular myocytes.

Authors:  F G de Lorenzi; T R Bridal; W Spinelli
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

Review 10.  Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.

Authors:  A Del Favero; F Roila; M Tonato
Journal:  Drug Saf       Date:  1993-12       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.